BOSTON (1-31-12) -- Long duration, controllable drug delivery is of wide interest to medical researchers and clinicians, particularly those seeking to improve treatment for patients with chronic pain or to prevent cancer recurrence after surgery. Now a team of researchers led by Boston University Biomedical Engineer and Chemist Mark Grinstaff ...

(Boston University College of Engineering) A team of researchers led by Boston University biomedical engineer and chemist Mark Grinstaff has developed a unique material and drug delivery mechanism that could pave the way for implants that release a drug at a designated rate for months.

Children's Hospital Boston has agreed to a three-year contract with Blue Cross Blue Shield of Massachusetts that will not pay Children's any more money this year, offering fresh evidence that the clamor to contain health costs is having an effect. In the second and third years of the pact, the ...

Boston Scientific Corporation announces that the U.S. District Court for the District of New Jersey has found all the asserted patents in a suit brought by Johnson & Johnson to be invalid and entered judgment in favor of Boston Scientific.

Boston Scientific Corporation reports nine-month clinical endpoint data from its ORION trial, demonstrating excellent outcomes for the Company's Epic Self-Expanding Nitinol Stent System in patients with iliac artery disease, a form of peripheral artery disease associated with severe leg pain caused by insufficient blood flow.

(Boston) A review article by researchers at Boston University School of Medicine (BUSM) debunks the widely-believed concept that hypertension, or high blood pressure, is the result of excess salt causing an increased blood volume, exerting extra pressure on the arteries. Published online in the Journal of Hypertension , ...

(Boston University Medical Center) A review article by researchers at Boston University School of Medicine debunks the widely believed concept that hypertension, or high blood pressure, is the result of excess salt causing an increased blood volume, exerting extra pressure on the arteries.

(AP) -- Arline MacCormack first heard about DES from her mother when she was 17. Three decades later, MacCormack believes that the drug her mother took to prevent miscarriages caused her to develop breast cancer at age 44.

(Boston) - Patricia F. Coogan, ScD, an associate professor of epidemiology at Boston University's Slone Epidemiology Center (SEC), recently was awarded funding for two grants from the National Institutes of Health. The first is a five-year grant from the National Institute of Environmental Health Sciences that will study air pollution ...

(Boston University Medical Center) Patricia F. Coogan, Sc.D., an associate professor of epidemiology at Boston University's Slone Epidemiology Center, recently was awarded funding for two grants from the National Institutes of Health. The first is a five-year grant from the National Institute of Environmental Health Sciences The second award ...

Boston Scientific Corporation announced that, along with today's introduction of a new family of INCEPTA and ENERGEN implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds), it is providing an extended warranty for these devices in the U.S. and many international countries of up to 10 years, depending on ...

BOSTONA combination of two drugs may alleviate radiation sickness in people who have been exposed to high levels of radiation, even when the therapy is given a day after the exposure occurred, according to a study led by scientists from Dana-Farber Cancer Institute and Children's Hospital Boston. ...